Biomarkers in sarcoidosis: a review

License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php Current Biomarker Findings 2014:4 93–106 Current Biomarker Findings Dovepress

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  2014-08-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.2147/CBF.S46196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prognostic value of red cell distribution width in patients with sarcoidosis

  2015cited by this paper
• Localization of the immune response in sarcoidosis.

  2015influential reference
• Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis

  2014cited by this paper
• Calcium and vitamin D metabolism in sarcoidosis.

  2013cited by this paper
• Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?

  2013cited by this paper
• Exhaled breath condensate: a comprehensive update

  2013cited by this paper
• Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

  2013cited by this paper
• Laboratory Investigations and Immunological Testing in Sarcoidosis

  2013cited by this paper
• Recent advances in the genetics of sarcoidosis

  2013cited by this paper
• References Subscriptions Permissions Email Alerts T Cell Responses to Mycobacterial Catalase-Peroxidase Profile a Pathogenic Antigen in Systemic Sarcoidosis

  2013cited by this paper
• Plasma level of interferon γ induced protein 10 is a marker of sarcoidosis disease activity.

  2013cited by this paper
• Measurement of neopterin, TGF-β1 and ACE in the exhaled breath condensate of patients with sarcoidosis

  2013cited by this paper
• Interferon-inducible chemokines reflect severity and progression in sarcoidosis

  2013cited by this paper
• Differential expression of microRNA and predicted targets in pulmonary sarcoidosis.

  2012cited by this paper
• Peripheral blood responses to specific antigens and CD28 in sarcoidosis.

  2012cited by this paper
• Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis.

  2012cited by this paper
• Is Analysis of Exhaled Breath Condensate an Equivalent to Bronchoalveolar Lavage Fluid in Sarcoidos is Patients

  2012cited by this paper
• Results of tetanus vaccination in sarcoidosis.

  2012cited by this paper
• Molecular profiling and gene expression analysis in cutaneous sarcoidosis: the role of interleukin-12, interleukin-23, and the T-helper 17 pathway.

  2012cited by this paper
• Quantitative intact proteomics investigations of alveolar macrophages in sarcoidosis

  2012cited by this paper
• The potential of the immunological markers of sarcoidosis in exhaled breath and peripheral blood as future diagnostic and monitoring techniques

  2011cited by this paper
• CXCR3 ligands: redundant, collaborative and antagonistic functions

  2011cited by this paper
• Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection.

  2011cited by this paper
• Changed phagocytic activity and pattern of Fcγ and complement receptors on blood monocytes in sarcoidosis.

  2011cited by this paper
• IGRAs for tuberculosis in sarcoidosis patients: is the immune response to mycobacteria helpful in the differential diagnosis or still a confounding factor?

  2011cited by this paper
• Correlation between Eicosanoids in Bronchoalveolar Lavage Fluid and in Exhaled Breath Condensate

  2011cited by this paper
• The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ

  2011influential reference
• Review: role of genetics in susceptibility and outcome of sarcoidosis.

  2010cited by this paper
• Immunologic response of sarcoidosis.

  2010influential reference
• Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis.

  2010cited by this paper
• [Markers of fibrosis and inflammation in exhaled breath condensate (EBC) and bronchoalveolar lavage fluid (BALF) of patients with pulmonary sarcoidosis -- a pilot study].

  2010cited by this paper
• Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.

  2010cited by this paper
• Calcium and Vitamin D in Sarcoidosis: How to Assess and Manage

  2010cited by this paper
• Comparative evaluation of serum markers in pulmonary sarcoidosis.

  2010cited by this paper
• Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2.

  2010cited by this paper
• Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis

  2010cited by this paper
• Robust microRNA stability in degraded RNA preparations from human tissue and cell samples.

  2010cited by this paper
• Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis.

  2010cited by this paper
• Dendritic cells in the pathogenesis of sarcoidosis.

  2010cited by this paper
• Exhaled 8-isoprostane as a prognostic marker in sarcoidosis. A short term follow-up

  2010cited by this paper
• Sarcoidosis

  2009cited by this paper
• Cellular microRNA and P bodies modulate host-HIV-1 interactions.

  2009cited by this paper
• International Criteria for the Diagnosis of Ocular Sarcoidosis: Results of the First International Workshop on Ocular Sarcoidosis (IWOS)

  2009cited by this paper
• Antimycobacterial immune responses in patients with pulmonary sarcoidosis

  2009cited by this paper
• Cellular Responses to Mycobacterial Antigens Are Present in Bronchoalveolar Lavage Fluid Used in the Diagnosis of Sarcoidosis

  2009cited by this paper
• Gene polymorphisms of ACE and the angiotensin receptor AT2R1 influence serum ACE levels in sarcoidosis.

  2009cited by this paper
• Protein levels of CC chemokine ligand (CCL)15, CCL16 and macrophage stimulating protein in patients with sarcoidosis

  2009cited by this paper
• CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis

  2009cited by this paper
• Role of integrin-mediated TGFbeta activation in the pathogenesis of pulmonary fibrosis.

  2009cited by this paper
• Multiple flow rates measurement of exhaled nitric oxide in patients with sarcoidosis: a pilot feasibility study.

  2009cited by this paper
• Immune response CC chemokines CCL2 and CCL5 are associated with pulmonary sarcoidosis

  2009cited by this paper
• Advances in the genetics of sarcoidosis

  2008cited by this paper
• Induced sputum in patients with interstitial lung disease: a non-invasive surrogate for certain parameters in bronchoalveolar lavage fluid.

  2008cited by this paper
• Exhaled carbon monoxide in sarcoidosis.

  2008cited by this paper
• Circulating levels of both Th1 and Th2 chemokines are elevated in patients with sarcoidosis.

  2008cited by this paper
• Intracellular cytokine profiles and T cell activation in pulmonary sarcoidosis.

  2008cited by this paper
• Phenotyping sarcoidosis from a pulmonary perspective.

  2008cited by this paper
• The Anergic State in Sarcoidosis Is Associated with Diminished Dendritic Cell Function1

  2008cited by this paper
• Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.

  2008cited by this paper
• Human Chitotriosidase: A Potential New Marker of Sarcoidosis Severity

  2008cited by this paper
• Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas.

  2008cited by this paper
• The diagnosis of sarcoidosis.

  2008cited by this paper
• Diagnosis of sarcoidosis

  2008cited by this paper
• Mycobacterium tuberculosis Antigen 85A Induces Th-1 Immune Responses in Systemic Sarcoidosis

  2007cited by this paper
• Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals.

  2007cited by this paper
• Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.

  2007cited by this paper
• CXCL9 and 11 in patients with pulmonary sarcoidosis: a role of alveolar macrophages

  2007cited by this paper
• Advances in the genetics of sarcoidosis.

  2007cited by this paper
• A Half-Space Approach to Order Dimension

  2007cited by this paper
• Role of CD4+ T cells in sarcoidosis.

  2007influential reference
• Chitotriosidase analysis in bronchoalveolar lavage of patients with sarcoidosis.

  2007cited by this paper
• A quantitative proteomic analysis of soluble bronchoalveolar fluid proteins from patients with sarcoidosis and chronic beryllium disease.

  2007influential reference
• Elevated serum neopterin levels in sarcoidosis

  2007cited by this paper
• Comparison of biomarkers in exhaled breath condensate and bronchoalveolar lavage.

  2007cited by this paper
• Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis.

  2007cited by this paper
• Role of genetic polymorphisms in ACE and TNF-α gene in sarcoidosis: a meta-analysis

  2007cited by this paper
• Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

  2007cited by this paper
• Mycobacterial heat shock protein‐induced blood T lymphocytes subsets and cytokine pattern: Comparison of sarcoidosis with tuberculosis and healthy controls

  2007cited by this paper
• Comparison of an Interferon-γ Release Assay with Tuberculin Skin Testing in HIV-infected Individuals

  2007cited by this paper
• Mycobacterium tuberculosis Complex and Mycobacterial Heat Shock Proteins in Lymph Node Tissue from Patients with Pulmonary Sarcoidosis

  2006cited by this paper
• Cellular Recognition of Mycobacterium tuberculosis ESAT-6 and KatG Peptides in Systemic Sarcoidosis

  2006cited by this paper
• The immune paradox of sarcoidosis and regulatory T cells

  2006influential reference
• Transforming growth factor-beta gene polymorphisms in sarcoidosis patients with and without fibrosis.

  2006cited by this paper
• Sarcoidosis: the nephrologist's perspective.

  2006influential reference
• Macrophage‐stimulating protein differently affects human alveolar macrophages from smoker and non‐smoker patients: evaluation of respiratory burst, cytokine release and NF‐κB pathway

  2006cited by this paper
• Inflammatory markers in the exhaled breath condensate of patients with pulmonary sarcoidosis.

  2006cited by this paper
• Serum anti-mycobacterial heat shock proteins antibodies in sarcoidosis and tuberculosis.

  2006cited by this paper
• Increased endothelin‐1 levels of BAL fluid in patients with pulmonary sarcoidosis

  2006cited by this paper
• Comparative Analysis of Mycobacterial Heat Shock Proteins-Induced Apoptosis of Peripheral Blood Mononuclear Cells in Sarcoidosis and Tuberculosis

  2006cited by this paper
• Protein profiles of bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

  2006cited by this paper
• Fungal infections as a complication of therapy for sarcoidosis.

  2005cited by this paper
• Cytokine profile and proteome analysis in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis

  2005cited by this paper
• [Comparison of oxidative stress markers in exhaled breath condensate and in serum of patients with tuberculosis and sarcoidosis].

  2005cited by this paper
• Immunology and pathophysiology

  2005cited by this paper
• Th1/Th2 cytokine pattern in bronchoalveolar lavage fluid and induced sputum in pulmonary sarcoidosis

  2005cited by this paper
• Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis

  2005cited by this paper
• The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites.

  2005cited by this paper
• Mycobacterial heat shock protein 70 induces interleukin‐10 production: immunomodulation of synovial cell cytokine profile and dendritic cell maturation

  2004cited by this paper
• CCL16/LEC powerfully triggers effector and antigen‐presenting functions of macrophages and enhances T cell cytotoxicity

  2004cited by this paper
• The chemokine system in diverse forms of macrophage activation and polarization.

  2004cited by this paper

• Non-Coding RNAs in Pulmonary Diseases: Comparison of Different Airway-Derived Biosamples

  2023cites this paper
• Novel biomarkers for the assessment of disease activity in patients with sarcoidosis: a case-control study

  2023cites this paper
• Routine Laboratory Biomarkers As Prognostic Indicators of Cardiac Sarcoidosis Outcomes

  2022cites this paper
• Acute Phase Reactants: Relevance in Dermatology

  2022influential citation
• Clinical significance of detection of mononuclear phagocyte subsets in blood and bronchoalveolar lavage fluid (BALF) in pulmonary sarcoidosis.

  2022cites this paper
• The utility of neutrophil-to-lymphocyte ratio determined at initial diagnosis in predicting disease stage and discriminating between active and stable disease in patients with sarcoidosis: a cross-sectional study

  2022cites this paper
• Prognostic value of inflammatory markers determined during diagnosis in patients with sarcoidosis: chronic versus remission.

  2021cites this paper
• Potential use of biomarkers for the clinical evaluation of sarcoidosis

  2021cites this paper
• Soluble interleukin-2 receptor in exhaled breath condensate in pulmonary sarcoidosis: a cross-sectional pilot study

  2020cites this paper
• Sarcoid Heart Disease: A Case Report and Literature Review

  2020cites this paper
• Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype.

  2020cites this paper
• MicroRNAs in pulmonary sarcoidosis: A systematic review.

  2020cites this paper
• The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review

  2019cites this paper
• Echogenic lymph nodes in the differential diagnosis of pediatric sarcoidosis

  2019cites this paper
• Pleuroparenchymal sarcoidosis - A recognised but rare manifestation of disease. Respiratory

  2018cites this paper
• Serum krebs von den lungen-6 (KL-6): a promising biomarker in sarcoidosis

  2018cites this paper
• Pleuroparenchymal sarcoidosis - A recognised but rare manifestation of disease

  2018cites this paper
• YKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity

  2018cites this paper
• Influence of complex therapy on the concentrations of C-reactive protein and interleukin-2 in patients with pulmonary sarcoidosis

  2017influential citation
• Prognostic Assessment of the Inflammatory Process Activity in Sarcoidosis of Respiratory Organs: Potential Use of C-reactive Protein and TNF-α

  2017cites this paper
• Animal models of sarcoidosis

  2016cites this paper
• Biomarkers in interstitial lung disease: moving towards composite indexes and multimarkers?

  2015cites this paper